The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy
Ischemic cardiomyopathy (ICM) is becoming a leading cause of morbidity and mortality in the whole world. Stem cell-based therapy is emerging as a promising option for treatment of ICM. Several stem cell types including cardiac-derived stem cells (CSCs), bone marrow-derived stem cells, mesenchymal st...
Saved in:
Main Authors: | Xianyun Wang (Author), Jun Zhang (Author), Fan Zhang (Author), Jing Li (Author), Yaqi Li (Author), Zirui Tan (Author), Jie Hu (Author), Yixin Qi (Author), Quanhai Li (Author), Baoyong Yan (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in the Treatment of Ischemic Diseases by Mesenchymal Stem Cells
by: Shujing Li, et al.
Published: (2016) -
The Application Potential and Advance of Mesenchymal Stem Cell-Derived Exosomes in Myocardial Infarction
by: Xianyun Wang, et al.
Published: (2021) -
Nanoparticles-Assisted Stem Cell Therapy for Ischemic Heart Disease
by: Kai Zhu, et al.
Published: (2016) -
The Relationship Between Plasma Selenium, Antioxidant Status, Inflammatory Responses and Ischemic Cardiomyopathy: A Case-Control Study Based on Matched Propensity Scores
by: Luo Y, et al.
Published: (2022) -
Modular networks and genomic variation during progression from stable angina pectoris through ischemic cardiomyopathy to chronic heart failure
by: Lin Chen, et al.
Published: (2022)